| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 10/10/2001 | EP1141335A2 Chemically modified enzymes with multiple charged variants |
| 10/10/2001 | EP1141323A1 Mammalian lysophosphatidic acid acyltransferase |
| 10/10/2001 | EP1141304A2 Production of recombinant monellin using methylotrophic yeast expression system |
| 10/10/2001 | EP1141297A2 Interleukin-17 related mammalian cytokines. polynucleotides encoding them . uses |
| 10/10/2001 | EP1141284A2 Methods and compositions for inhibiting neoplastic cell growth |
| 10/10/2001 | EP1141262A1 Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in an active site loop region |
| 10/10/2001 | EP1141261A1 Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in an active site loop region |
| 10/10/2001 | EP1141260A1 Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in an active site loop region |
| 10/10/2001 | EP1141256A1 Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in an active site loop region |
| 10/10/2001 | EP1141255A1 Modified forms of hepatitis c virus ns3 protease |
| 10/10/2001 | EP1141248A2 A METHOD FOR THE HIGH LEVEL EXPRESSION OF ACTIVE LYMPHOTOXIN-$g(b) RECEPTOR IMMUNOGLOBULIN CHIMERIC PROTEINS AND THEIR PURIFICATION |
| 10/10/2001 | EP1141245A1 Somatic cells with ablated prp gene and methods of use |
| 10/10/2001 | EP1141238A1 Production of proteins |
| 10/10/2001 | EP1141236A1 Enzymatic production of difructose dianhydride iv from sucrose and relevant enzymes and genes coding for them |
| 10/10/2001 | EP1141235A2 (bifidobacterium) in the treatment of inflammatory disease |
| 10/10/2001 | EP1141205A1 Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in the active site loop region |
| 10/10/2001 | EP1141022A1 Serine protease inhibitor |
| 10/10/2001 | EP1141012A1 Modification of interferon alpha production |
| 10/10/2001 | EP1141002A1 Human cervical cancer 1 protooncogene and protein encoded therein |
| 10/10/2001 | EP1141001A2 Screening methods based on the use of protein kinases |
| 10/10/2001 | EP1140994A1 Outer surface proteins, their genes, and their use |
| 10/10/2001 | EP1140938A2 High affinity inhibitors for target validation and uses thereof |
| 10/10/2001 | EP1140928A2 Microbial transformation method for the preparation of an epothilone |
| 10/10/2001 | EP1140885A1 Method for high yield extraction of paclitaxel from paclitaxel-containing material |
| 10/10/2001 | EP1140199A1 Hyaluronate lyase used for promoting penetration in topical agents |
| 10/10/2001 | EP1140171A1 Methods and products for regulating lectin complement pathway associated complement activation |
| 10/10/2001 | EP1140164A2 Multivalent immunogenic composition containing rsv subunit composition and influenza virus preparation |
| 10/10/2001 | EP0863950B1 Hair dyeing composition |
| 10/10/2001 | EP0790767B1 Wound repair dressings and methods for their preservation |
| 10/10/2001 | CN1317050A Nucleotide sequences which code for the tal gene |
| 10/10/2001 | CN1317049A Nucleotide sequences which code for the opc A gene |
| 10/10/2001 | CN1317044A Nucleic acids encoding proteins involved in sensory transduction |
| 10/10/2001 | CN1317043A Polypeptides and polynucleotides from coagulase-negative staphylocoui |
| 10/10/2001 | CN1317042A Bacteiral strains for production of 2-keto-L-guolonic acid |
| 10/10/2001 | CN1317010A Nucleic acids encoding G-protein coupled receptor involved in sensory |
| 10/10/2001 | CN1317008A Novel antibacterial compounds |
| 10/10/2001 | CN1316987A Microbial processf or preparation of acetic acid as well as solvent for its extraction from fermentation liquid |
| 10/10/2001 | CN1316878A Method of performing transgenesis |
| 10/10/2001 | CN1316520A Recombination producing of carotenoid especially astaxanthin and its utilized biological material |
| 10/10/2001 | CN1316517A Leavo-dikotone reductase gene and its usage |
| 10/10/2001 | CN1316516A Coded rpilk gene nucleotide sequence and its using method |
| 10/10/2001 | CN1072721C Process for producing L-leucine |
| 10/10/2001 | CN1072718C Lipase and its micro-organism process for producing the lipase, and use |
| 10/10/2001 | CN1072650C Bibenzo-oxazepine and -dioxepine derivatives and their use as anti-tumor agent |
| 10/09/2001 | US6300544 Cytochrome P450 monooxygenases |
| 10/09/2001 | US6300490 Expression vector coding cytosine deaminase; for use in the treatment of cancers |
| 10/09/2001 | US6300474 Modified interferons |
| 10/09/2001 | US6300121 Method for reducing bioavailability of lead by a lead-sequestering soil bacterium |
| 10/09/2001 | US6300116 Modified protease having improved autoproteolytic stability |
| 10/09/2001 | US6300102 Immunogenic hybrid protein OprF-Oprl derived from Pseudomonas aeruginosa membrane proteins |
| 10/09/2001 | US6300100 Process for preparing tissue factor pathway inhibitor |
| 10/09/2001 | US6300095 A dna fragment used for blocking genetic expression through antisense constructs and for increased antibiotic production |
| 10/09/2001 | US6300094 Polynucleotides encoding a novel ABC transporter |
| 10/09/2001 | US6300068 Nucleic acid assays |
| 10/09/2001 | US6300067 TFIIB transcription factor from Candida albicans and methods of screening for inhibitors of Candida albicans growth |
| 10/09/2001 | US6300056 A synthetic oligonulceotide having one segment homologous with a segment of hiv nucleic acid and a second segment of a nucleotide sequence which is homologous to an oligonucleotide segment of a nucleic acid multimer not complementary to hiv |
| 10/09/2001 | US6300054 Astrocyte apparatus for bioprocessing a circulating fluid |
| 10/09/2001 | US6299882 UL54.5 of Marek's disease virus (MDV) |
| 10/09/2001 | CA2235025C Bone morphogenetic protein and fibroblast growth factor compositions and methods for the induction of cardiogenesis |
| 10/09/2001 | CA2179656C Chromosomal expression of heterologous genes in bacterial cells |
| 10/09/2001 | CA1341302C Yeast expression systems with vectors having gapdh or pyk promoters and synthesis of foreign protein |
| 10/09/2001 | CA1341301C Preparation of functional human urokinase proteins |
| 10/09/2001 | CA1341300C Recombinant dna means and method for producing bovine rennin and precursors |
| 10/07/2001 | CA2342961A1 Immunoassay for lsd and 2-oxo-3-hydroxy-lsd |
| 10/05/2001 | CA2340300A1 Nucleotide sequences that code for the rplk gene and methods of use thereof |
| 10/04/2001 | WO2001073108A2 A bacterial two-hybrid system for protein interaction screening |
| 10/04/2001 | WO2001073104A1 Beta-glucans from filamentous fungi |
| 10/04/2001 | WO2001073052A2 Thermophilic polymerase iii holoenzyme |
| 10/04/2001 | WO2001073033A2 Anti-angiogenic and anti-tumor properties of matin and other laminin domains |
| 10/04/2001 | WO2001073025A2 Anti-angiogenic and anti-tumor properties of vascostatin and other nidogen domains |
| 10/04/2001 | WO2001072953A1 Carrier for animal cell culture comprising organ tissue slice and animal cell culture method and transplantation method with the use of the carrier |
| 10/04/2001 | WO2001072773A2 Genes isolated from dendritic cells, gene products and methods employing the same |
| 10/04/2001 | WO2001016319A3 Compositions and methods for the treatment of immune related diseases |
| 10/04/2001 | WO2001012778A3 Flocculation of cell material |
| 10/04/2001 | WO2000058351A3 ZWITTERMICIN A BIOSYNTHETIC GENE FROM $i(BACILLUS CEREUS) |
| 10/04/2001 | WO2000043515A3 Methods of monitoring hiv drug resistance |
| 10/04/2001 | WO2000017327A9 Terpene synthases |
| 10/04/2001 | WO1999055860A8 Host-encoded protein expressed on marek's disease (mdv)-infected cells and antibody thereto |
| 10/04/2001 | US20010027184 Serine/threonine protein kinase (H-SGK2) |
| 10/04/2001 | US20010026940 Biopesticides |
| 10/04/2001 | US20010026934 Conversion of compactin to pravastatin by actinomadura |
| 10/04/2001 | US20010026933 Intermediate for production of vitamin c |
| 10/04/2001 | US20010026932 Agonist anti-CD40 molecules, including monoclonal antibodies, which can bind to and stimulate professional and non-professional human antigen-presenting cells; may be useful as antitumor agents |
| 10/04/2001 | US20010026931 Accelerates differentiation of megakaryocytes in the presence of IL-3, and acts as a thrombopoietin, and therefore an effective medicament to various diseases involving a decrease in platelets |
| 10/04/2001 | EP1138786A2 Specific and universal amplification primers to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories |
| 10/04/2001 | EP1138775A2 Method of preparing a guanosine-group compound and an intermediate thereof |
| 10/04/2001 | EP1138774A2 Defective recombinant adenoviruses expressing cytokines for use in antitumoral treatement |
| 10/04/2001 | EP1138770A2 Polyhydroxyalkanoate synthase and gene encoding the same enzyme |
| 10/04/2001 | EP1138769A1 Recombinant L-alpha-glycerophosphate oxidase gene, and method for producing the same |
| 10/04/2001 | EP1138766A2 Process for preparing major histocompatibility antigen class II protein and materials having the same immobilized thereon |
| 10/04/2001 | EP1138759A2 A method of producing a polyunsaturated fatty acid containing culture and polyunsaturated fatty acid-containing oil using microorganisms |
| 10/04/2001 | EP1137797A1 Expression system for factor viii |
| 10/04/2001 | EP1137767A1 Vectors having terminal repeat sequence of epstein-barr virus |
| 10/04/2001 | EP1137763A1 Glucoamylases with n-terminal extensions |
| 10/04/2001 | EP1137758A2 Method and composition for preserving viruses |
| 10/04/2001 | EP0973800A4 Novel receptor |
| 10/04/2001 | EP0835309B1 Vaccine for infectious agents, composition for treating and preventing hiv infections |
| 10/04/2001 | EP0835132B1 Recombinant temperature sensitive mutants of influenza virus |
| 10/04/2001 | EP0802920B1 Antifungal fusacandins |
| 10/04/2001 | EP0772632B1 T cell stimulating protein of pestivirus |